NCT04424836View on ClinicalTrials.gov

HFNC Treatment in COVID-19 Pneumonia

CompletedOBSERVATIONAL
Enrollment

43

Participants

Timeline

Start Date

May 15, 2020

Primary Completion Date

June 4, 2020

Study Completion Date

June 5, 2020

Conditions
Coronavirus InfectionPneumonia, ViralAcute Respiratory Failure
Interventions
DEVICE

high flow nasal cannula device

device is supplying oxygen with heated and humidified air in a high flow rate

Trial Locations (1)

34371

Sisli Etfal Research and Training Hospital, Istanbul

All Listed Sponsors
lead

Sisli Hamidiye Etfal Training and Research Hospital

OTHER

NCT04424836 - HFNC Treatment in COVID-19 Pneumonia | Biotech Hunter | Biotech Hunter